PDLI has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Fees and other income is the income earned by insurance companies other than providing insurances. PDL BioPharma Inc's fees and other income for the three months ended in Mar. 2014 was $139.7 Mil. Its fees and other income for the trailing twelve months (TTM) ended in Mar. 2014 was $490.7 Mil.
PDL BioPharma Inc's quarterly fees and other income increased from Sep. 2013 ($97.3 Mil) to Dec. 2013 ($110.1 Mil) and increased from Dec. 2013 ($110.1 Mil) to Mar. 2014 ($139.7 Mil).
PDL BioPharma Inc's annual fees and other income increased from Dec. 2011 ($362.0 Mil) to Dec. 2012 ($374.5 Mil) and increased from Dec. 2012 ($374.5 Mil) to Dec. 2013 ($442.9 Mil).
Income earned by insurance companies other than providing insurances. It includes investing income, fees and interest income.
PDL BioPharma Inc Fees and Other Income for the trailing twelve months (TTM) ended in Mar. 2014 was 143.617 (Jun. 2013 ) + 97.314 (Sep. 2013 ) + 110.143 (Dec. 2013 ) + 139.664 (Mar. 2014 ) = $490.7 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
PDL BioPharma Inc Annual Data
PDL BioPharma Inc Quarterly Data